Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity
- PMID: 33799892
- PMCID: PMC7998217
- DOI: 10.3390/microorganisms9030578
Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity
Abstract
Leishmaniasis, a chronic and persistent intracellular protozoal infection caused by many different species within the genus Leishmania, is an unfamiliar disease to most North American providers. Clinical presentations may include asymptomatic and symptomatic visceral leishmaniasis (so-called Kala-azar), as well as cutaneous or mucosal disease. Although cutaneous leishmaniasis (caused by Leishmania mexicana in the United States) is endemic in some southwest states, other causes for concern include reactivation of imported visceral leishmaniasis remotely in time from the initial infection, and the possible long-term complications of chronic inflammation from asymptomatic infection. Climate change, the identification of competent vectors and reservoirs, a highly mobile populace, significant population groups with proven exposure history, HIV, and widespread use of immunosuppressive medications and organ transplant all create the potential for increased frequency of leishmaniasis in the U.S. Together, these factors could contribute to leishmaniasis emerging as a health threat in the U.S., including the possibility of sustained autochthonous spread of newly introduced visceral disease. We summarize recent data examining the epidemiology and major risk factors for acquisition of cutaneous and visceral leishmaniasis, with a special focus on implications for the United States, as well as discuss key emerging issues affecting the management of visceral leishmaniasis.
Keywords: asymptomatic visceral leishmaniasis; autochthonous leishmaniasis; climate change; immunosuppression; transfusion transmission; travel-related leishmaniasis.
Conflict of interest statement
The content and views expressed in this article are those of the author and do not reflect the official policy of the Department of the Army/Navy/Air Force, Department of Defense, or U.S. Government. The authors declare no financial conflict of interest relevant to this review. J.M.C. and N.E.A. receive Department of Defense funding to study asymptomatic visceral leishmaniasis. N.E.A. receives royalties from Elsevier and UpToDate for editorial and chapter writing activities. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures

Similar articles
-
Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study.Lancet Microbe. 2021 Jan;2(1):e23-e31. doi: 10.1016/S2666-5247(20)30166-X. Lancet Microbe. 2021. PMID: 33615281 Free PMC article.
-
Incidence of Endemic Human Cutaneous Leishmaniasis in the United States.JAMA Dermatol. 2018 Sep 1;154(9):1032-1039. doi: 10.1001/jamadermatol.2018.2133. JAMA Dermatol. 2018. PMID: 30046836 Free PMC article.
-
Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report.Rev Soc Bras Med Trop. 2018 Jan-Feb;51(1):105-107. doi: 10.1590/0037-8682-0487-2016. Rev Soc Bras Med Trop. 2018. PMID: 29513829
-
Leishmaniasis in travelers: a literature review.Travel Med Infect Dis. 2014 Nov-Dec;12(6 Pt A):563-81. doi: 10.1016/j.tmaid.2014.09.007. Epub 2014 Sep 28. Travel Med Infect Dis. 2014. PMID: 25287721 Review.
-
[Cutaneous leishmaniasis].Ann Dermatol Venereol. 2019 Mar;146(3):232-246. doi: 10.1016/j.annder.2019.02.002. Epub 2019 Mar 15. Ann Dermatol Venereol. 2019. PMID: 30879803 Review. French.
Cited by
-
Modulation of Macrophage Redox and Apoptotic Processes to Leishmania infantum during Coinfection with the Tick-Borne Bacteria Borrelia burgdorferi.Pathogens. 2023 Sep 4;12(9):1128. doi: 10.3390/pathogens12091128. Pathogens. 2023. PMID: 37764937 Free PMC article.
-
Operational Risk Assessment Tool for Evaluating Leishmania infantum Introduction and Establishment in the United States through Dog Importation1.Emerg Infect Dis. 2024 Dec;30(12):1-14. doi: 10.3201/eid3012.231084. Emerg Infect Dis. 2024. PMID: 39592889 Free PMC article.
-
A case of adnexal cutaneous leishmaniasis in Washington DC.J Ophthalmic Inflamm Infect. 2024 Aug 23;14(1):41. doi: 10.1186/s12348-024-00423-z. J Ophthalmic Inflamm Infect. 2024. PMID: 39174810 Free PMC article.
-
Single-cell ATAC sequencing identifies sleepy macrophages during reciprocity of cytokines in L. major infection.Microbiol Spectr. 2024 Mar 5;12(3):e0347823. doi: 10.1128/spectrum.03478-23. Epub 2024 Feb 1. Microbiol Spectr. 2024. PMID: 38299832 Free PMC article.
-
Is leishmaniasis the new emerging zoonosis in the world?Vet Res Commun. 2023 Dec;47(4):1777-1799. doi: 10.1007/s11259-023-10171-5. Epub 2023 Jul 12. Vet Res Commun. 2023. PMID: 37438495 Review.
References
-
- Stahlman S., Williams V.F., Taubman S.B. Incident diagnoses of leishmaniasis, active and reserve components, U.S. Armed Forces, 2001–2016. MSMR. 2017;24:2–7. - PubMed
-
- Mody R.M., Lakhal-Naouar I., Sherwood J.E., Koles N.L., Shaw D., Bigley D.P., Co E.-M.A., Copeland N.K., Jagodzinski L.L., Mukbel R.M., et al. Asymptomatic Visceral Leishmania infantum Infection in US Soldiers Deployed to Iraq. Clin. Infect. Dis. 2019;68:2036–2044. doi: 10.1093/cid/ciy811. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources